Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$16.78 - $31.94 $151,020 - $287,460
9,000 New
9,000 $269,000
Q4 2021

Feb 11, 2022

SELL
$21.52 - $36.02 $193,680 - $324,180
-9,000 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$27.42 - $48.97 $246,780 - $440,730
-9,000 Reduced 50.0%
9,000 $269,000
Q2 2018

Aug 03, 2018

BUY
$14.58 - $23.0 $262,440 - $414,000
18,000 New
18,000 $0

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $663M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Cobblestone Capital Advisors LLC Portfolio

Follow Cobblestone Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cobblestone Capital Advisors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Cobblestone Capital Advisors LLC with notifications on news.